The Canadian firm Aphria is planning to launch an investment for the cultivation and production of medicinal in northeastern Greek region of Xanthi within 2018, Athens-Macedonian News Agency (ANA) sources said on Wednesday.
Representatives of the company had another meeting with Deputy Economy and Development Minister Stergios Pitsiorlas on Wednesday to discuss the planned investment, on a 5,000-hectare property, which is forecast to pump one billion euros into the Greek economy and create 450-500 jobs, the sources said.
The company is apparently hoping that the necessary procedures and joint ministerial decisions will be signed as soon as possible so that it can launch the investment before the end of the current year.
Aphria is a Canadian listed company that specialises in the production of industrial and medicinal cannabis and has operations in the United States, Canada and Germany.
ATHENS - Greece’s capital was throttled Sept.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.06 USD
